Decentralized Biobanking to Empower Patient Engagement in Biospecimen Research: Operational Feasibility Case StudyBiopreservation and BiobankingIF1.42025-10-010PRE
Incidence and mortality of endometrial cancer in the Appalachian Eastern Kentucky continues to rise due to obesity, metabolic syndromes, and corresponding health disparities阿巴拉契亚东肯塔基州子宫内膜癌的发病率和死亡率持续上升,原因包括肥胖、代谢综合征以及相应的健康差异。LANCET REGIONAL HEALTH-AMERICASIF7.62025-07-010OA
Appalachia's worsening disparities in cancer mortality should be viewed as a regional manifestation of widening global disparities in health outcomes rather than a uniquely American phenomenaLANCET REGIONAL HEALTH-AMERICASIF7.62024-09-010OAAI
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi studyECLINICALMEDICINEIF102024-07-010OAAI
REFRaME-O1/ENGOT-OV79/GOG-3086: A phase II/III open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator's choice of chemotherapy in women with relapsed platinum-resistant epithelial ovarian cancer expressing folate receptor alpha (FolRα)ANNALS OF ONCOLOGYIF65.42023-10-010PRE
Assessment of bladder filling during prostate cancer radiation therapy with ultrasound and cone-beam CTFRONTIERS IN ONCOLOGYIF3.32023-07-275OAAI
Protecting privacy and promoting learning: blockchain and privacy preserving technology should inform new ethical guidelines for health datahealth technology assessmentIF2.82021-08-204PREAI
Plan quality effects of maximum monitor unit constraints in pencil beam scanning proton therapy for central nervous system and skull base tumorsRADIOTHERAPY AND ONCOLOGYIF5.32021-07-011PREAI
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the OropharynxINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52021-06-010PRE
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])EUROPEAN JOURNAL OF CANCERIF7.12021-06-0116OAAI
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9FRONTIERS IN ONCOLOGYIF3.32021-05-116OAAI
Patient-Reported Quality of Life Before and After Chemoradiation for Intact Pancreas Cancer: A Prospective Registry StudyPRACTICAL RADIATION ONCOLOGYIF3.52021-01-016PREAI
Scholarly Publishing in the Wake of COVID-19INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52020-10-0117OAAI
Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM)INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52020-04-0116PREAI
TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trialBRITISH JOURNAL OF CANCERIF6.82020-02-1743OAAI
N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical TrialMAYO CLINIC PROCEEDINGSIF6.72019-09-0111OAAI
Patient-Reported Quality of Life During Chemoradiation for Intact Pancreas Cancer: a Prospective Registry StudyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-09-011OAAI
Paid to Produce Data: Research Participation as the Labor of Generating Valuable Health DataAMERICAN JOURNAL OF BIOETHICSIF20.82019-08-161PREAI
The Insurance Approval Process for Proton Beam Therapy Must Change: Prior Authorization Is Crippling Access to Appropriate Health CareINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-07-0113OAAI